C12N 2740/11042
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2740/11042 (Virus or viral particle as vehicle) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 8
- Assignees
- 7
- Inventors
- 6
- Latest grant
- 30 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 2 |
By publication year.
Recent patents
- Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon30 Jul 2024US 12,049,639 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon8 Aug 2023US 11,718,861 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Delivery of packaged RNA to mammalian cells21 Jan 2020US 10,538,743 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Delivery of packaged RNA to mammalian cells29 Nov 2016US 9,506,041 B2The United States of America, as represented by the Secretary, Dept. of Health and Human Services
- Self-Amplifying RNA-Based VLP Vaccines22 Aug 2024US 2024/0277836 A1Chimeron Bio Corporation
- Compositions of glycoprotein particles27 Jun 2024US 2024/0207196 A1Scribe Therapeutics Inc.
- Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon17 Aug 2023US 2023/0257775 A1The USA as represented by the Secretary of Health and Human Services
- Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon3 Jun 2021US 2021/0163988 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Delivery of packaged rna to mammalian cells2 Apr 2020US 2020/0102545 A1The USA, as represented by the Secretary, Dept. of Health and Human Services
Most cited
By later US patents
- Delivery of packaged RNA to mammalian cells6US 10,538,743 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2020
- Delivery of packaged RNA to mammalian cells3US 9,506,041 B2The United States of America, as represented by the Secretary, Dept. of Health and Human Services · 2016
- Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon1US 11,718,861 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2023